![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Introduction to endpoints in oncology clinical trials (mycsg) View |
![]() |
Lecture Medical Oncology - Endpoints in clinical trials (European Association of Urology) View |
![]() |
Use of Surrogate Endpoints in Oncology (Duke Margolis) View |
![]() |
Phases of Cancer Clinical Trials – An Introduction, with Neal Meropol, MD (Cancer.Net) View |
![]() |
RECIST 1.0 and 1.1: Overview and Data Challenges in Oncology Clinical Trials Trailer (Kathy Barnett) View |
![]() |
Why Endpoints Matter in Clinical Trials, Daniel Leffler, MD (CeliacDiseaseFoundation) View |
![]() |
RECIST 1.0 and 1.1: Overview and Data Challenges in Oncology Clinical Trials Trailer (Kathy Barnett) View |
![]() |
Segment 5 - Surrogate End Points in Clinical Trials: The Right Information (AJMCtv) View |
![]() |
New endpoints in clinical trials to better serve patients (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Endpoints in Cancer Drug Development: HTA Perspective. Leeza Osipenko, PhD., 27/04/21. (Consilium Scientific) View |